Ondansetron HCl

FDA Drug Profile

Ondansetron HCl is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.

Drug details

Generic Name
Ondansetron HCl
Sponsor
Dr. Reddy's Laboratories Limited
NDC Codes
1
Dosage Forms
POWDER
Active Ingredients
ONDANSETRON HYDROCHLORIDE

Indications and Usage

1. Indications and Usage Section 1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.